Literature DB >> 9662491

A novel method for the visualization of the in situ mucus layer in rat and man.

N Jordan1, J Newton, J Pearson, A Allen.   

Abstract

1. The observed thickness of the gastric mucus barrier varies widely, even appearing discontinuous, depending on the methods used. Here we describe the development and application of a modified periodic acid Schiff/Alcian Blue staining technique for use on cryostat sections of gastric mucosa. This technique for the first time enables the preservation and visualization of the full thickness of the adherent gastric mucus layer and the underlying mucosa. 2. In designing this novel method we have selected those procedures which would result in the least alteration to the mucus layer. The methods used were snap freezing, cryostat sectioning of the whole stomach followed by brief ethanol pretreatment (10 min in 100% ethanol), a prolonged staining with periodic acid Schiff/Alcian Blue (15 min and 2.5 h respectively), a gentle post-fixation (45 min paraformaldehyde vapour at 37 degreesC) and the use of a water-soluble mountant. 3. A continuous, adherent mucus layer was observed over the surface of the rat gastric mucosa (periodic acid Schiff/Alcian Blue stained) and human gastric antral biopsies (periodic acid Schiff stained). In the rat the mean (S.D.) mucus thickness measurements along the antrum to oesophageal axis (which was divided histologically into four regions, A to D) were: A, 166 (47) micrometer; B, 179 (48) micrometer; C, 184 (50) micrometer; D (the non-glandular stratified epithelium at the top of the stomach), Absent. In human gastric antral biopsies the mean (S.D.) mucus thickness was 144 (52) micrometer. 4. This new technique has enabled the visualization and precise measurement of thickness of the gastric mucus layer in rat and man. The adherent gastric mucus layer was observed to be continuous in the rat glandular stomach and human antrum. In validation experiments in rat the mean mucus thickness measurements were found to be twice those measured by conventional histological techniques, in which the mucus layer appeared discontinuous and patchy. However, they were within the range of thickness values seen in unfixed tissues and in the rat in vivo preparation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662491

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  20 in total

1.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Food-associated stimuli enhance barrier properties of gastrointestinal mucus.

Authors:  Hasan M Yildiz; Lauren Speciner; Cafer Ozdemir; David E Cohen; Rebecca L Carrier
Journal:  Biomaterials       Date:  2015-03-27       Impact factor: 12.479

3.  Intestinal barrier analysis by assessment of mucins, tight junctions, and α-defensins in healthy C57BL/6J and BALB/cJ mice.

Authors:  Valentina Volynets; Andreas Rings; Gyöngyi Bárdos; Maureen J Ostaff; Jan Wehkamp; Stephan C Bischoff
Journal:  Tissue Barriers       Date:  2016-07-08

Review 4.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

5.  The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract.

Authors:  L Ma; W P Wang; J Y Chow; S K Lam; C H Cho
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

Authors:  P V Sherwood; J I D Wibawa; J C Atherton; N Jordan; D Jenkins; D A Barrett; P N Shaw; R C Spiller
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 8.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

Authors:  Samuel K Lai; Ying-Ying Wang; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2008-12-13       Impact factor: 15.470

9.  Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.

Authors:  Anisia J Silva; Gordon J Leitch; Andrew Camilli; Jorge A Benitez
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

10.  Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.

Authors:  Katsunori Iijima; T Ichikawa; S Okada; M Ogawa; T Koike; S Ohara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.